Amyloid-PET advocates take their case to Congress
January 30, 2020 -- Proponents of a bill pending in the U.S. Congress that would ensure adequate reimbursement for diagnostic radiopharmaceuticals for use with PET to diagnose Alzheimer's disease and other neurodegenerative conditions took their cause to the nation's capital on January 29.
Discuss
January 30, 2020 -- Proponents of a bill pending in the U.S. Congress that would ensure adequate reimbursement for diagnostic radiopharmaceuticals for use with PET to diagnose Alzheimer's disease and other neurodegenerative conditions took their cause to the nation's capital on January 29.
Discuss Biomarkers on PET, MRI show breast cancer risk
January 23, 2020 -- In a finding they described as "unexpected," researchers used PET and MRI to discover that women with a malignant tumor in one breast have lower levels of certain biomarkers in the contralateral, healthy breast. Results were published in the January edition of the Journal of Nuclear Medicine.
Discuss
January 23, 2020 -- In a finding they described as "unexpected," researchers used PET and MRI to discover that women with a malignant tumor in one breast have lower levels of certain biomarkers in the contralateral, healthy breast. Results were published in the January edition of the Journal of Nuclear Medicine.
Discuss Unique PET/CT video shows real-time blood, cardiac motion
January 22, 2020 -- U.S. and Chinese researchers have combined an advanced image reconstruction method with a total-body PET scanner to track real-time blood flow and heart and respiratory function, according to a study published online January 20 in the Proceedings of the National Academy of Sciences.
Discuss
January 22, 2020 -- U.S. and Chinese researchers have combined an advanced image reconstruction method with a total-body PET scanner to track real-time blood flow and heart and respiratory function, according to a study published online January 20 in the Proceedings of the National Academy of Sciences.
Discuss Report: Fujifilm makes pitch for Curium Pharma
January 16, 2020 -- In what would be its latest deal in an ongoing acquisition spree in healthcare, Fujifilm has made an offer to buy French radiopharmaceutical developer Curium Pharma in a transaction that could be valued as high as $3 billion, according to a January 14 report from Bloomberg.
Discuss
January 16, 2020 -- In what would be its latest deal in an ongoing acquisition spree in healthcare, Fujifilm has made an offer to buy French radiopharmaceutical developer Curium Pharma in a transaction that could be valued as high as $3 billion, according to a January 14 report from Bloomberg.
Discuss Cu-64 DOTATATE PET could handle neuroendocrine tumors
January 15, 2020 -- PET imaging with copper-64 (Cu-64) DOTATATE could become a lower-radiation dose option for patients with suspected neuroendocrine tumors, according to the results of a phase III clinical trial published online January 10 in the Journal of Nuclear Medicine.
Discuss
January 15, 2020 -- PET imaging with copper-64 (Cu-64) DOTATATE could become a lower-radiation dose option for patients with suspected neuroendocrine tumors, according to the results of a phase III clinical trial published online January 10 in the Journal of Nuclear Medicine.
Discuss Flortaucipir-PET shows moderate promise for CTE
January 7, 2020 -- PET imaging with flortaucipir revealed uptake patterns indicative of chronic traumatic encephalopathy (CTE) in a new study published online January 6 in JAMA Neurology, but the tau-binding radiotracer is not quite ready to be declared a reliable biomarker for the condition, the authors noted.
Discuss
January 7, 2020 -- PET imaging with flortaucipir revealed uptake patterns indicative of chronic traumatic encephalopathy (CTE) in a new study published online January 6 in JAMA Neurology, but the tau-binding radiotracer is not quite ready to be declared a reliable biomarker for the condition, the authors noted.
Discuss PET shows tau better predicts brain atrophy than amyloid
January 3, 2020 -- PET scans comparing the location and magnitude of tau protein accumulation have shown that tau better predicts future brain atrophy in patients with Alzheimer's disease compared with amyloid deposition -- and a year or more in advance, according to a study published online January 1 in Science Translational Medicine.
Discuss
January 3, 2020 -- PET scans comparing the location and magnitude of tau protein accumulation have shown that tau better predicts future brain atrophy in patients with Alzheimer's disease compared with amyloid deposition -- and a year or more in advance, according to a study published online January 1 in Science Translational Medicine.
Discuss Zr-89 immuno-PET could help predict cancer therapy outcomes
December 18, 2019 -- Researchers are one step closer to proving the worth of zirconium-89 (Zr-89) immuno-PET as a noninvasive approach to predict the effectiveness of therapy for cancerous tumors, according to a study published in the December issue of the Journal of Nuclear Medicine.
Discuss
December 18, 2019 -- Researchers are one step closer to proving the worth of zirconium-89 (Zr-89) immuno-PET as a noninvasive approach to predict the effectiveness of therapy for cancerous tumors, according to a study published in the December issue of the Journal of Nuclear Medicine.
Discuss Can FDG-PET/MRI replace biopsy in breast cancer cases?
December 11, 2019 -- Although FDG-PET/MRI shows promise for accurate staging of breast cancer, the modality still isn't as accurate as sentinel lymph node biopsy, according to a study presented last week at RSNA 2019 in Chicago.
Discuss
December 11, 2019 -- Although FDG-PET/MRI shows promise for accurate staging of breast cancer, the modality still isn't as accurate as sentinel lymph node biopsy, according to a study presented last week at RSNA 2019 in Chicago.
Discuss PET and prejudice: Insurance firms' misconceptions
December 10, 2019 -- Healthcare insurance companies should value PET imaging and its cost-effective contributions to patient outcomes rather than view the modality as too expensive and unworthy of reimbursement, according to an editorial in the December issue of the Journal of Nuclear Medicine.
Discuss
December 10, 2019 -- Healthcare insurance companies should value PET imaging and its cost-effective contributions to patient outcomes rather than view the modality as too expensive and unworthy of reimbursement, according to an editorial in the December issue of the Journal of Nuclear Medicine.
Discuss
Special Feature
Nuclear medicine guidelines promote COVID-19 safety
How can nuclear medicine departments keep patients and staff safe during the COVID-19 pandemic? A new set of guidelines from the IAEA provides some guidance.. Read more
Industry News
VENDOR CONNECT
Conferences
Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting -- Virtual Edition
July 11-14
Online
July 11-14
Online
2020 Annual Meeting of the Florida Radiological Society (FRS) & Florida Radiology Business Management Association (FRBMA)
July 17-19
Ft. Lauderdale, Florida United States
July 17-19
Ft. Lauderdale, Florida United States
Eastern Neuroradiological Society (ENRS) 2020 Annual Meeting
August 27-30
Burlington, Vermont United States
August 27-30
Burlington, Vermont United States
Vancouver Imaging Review: Head to Toe
September 24-26
Vancouver, British Columbia Canada
September 24-26
Vancouver, British Columbia Canada
American Society of Nuclear Cardiology (ASNC) Annual Scientific Session
September 24-27
Washington, District of Columbia United States
September 24-27
Washington, District of Columbia United States